<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>TYM on Korea Invest Insights</title><link>https://koreainvestinsights.com/tags/tym/</link><description>Recent content in TYM on Korea Invest Insights</description><generator>Hugo -- gohugo.io</generator><language>en</language><copyright>koreainvestinsights.com · @korea_invest_insights</copyright><lastBuildDate>Fri, 13 Nov 2026 23:34:41 +0900</lastBuildDate><atom:link href="https://koreainvestinsights.com/tags/tym/feed.xml" rel="self" type="application/rss+xml"/><item><title>Korea Quality Re-Rating Watch 2026-11-13: Dongkook, Coses, Celltrion</title><link>https://koreainvestinsights.com/post/kr-daily-wrap-2026-11-13/</link><pubDate>Fri, 13 Nov 2026 16:30:00 +0900</pubDate><guid>https://koreainvestinsights.com/post/kr-daily-wrap-2026-11-13/</guid><description>&lt;h2 id="macro-dashboard"&gt;Macro Dashboard
&lt;/h2&gt;&lt;table&gt;
 &lt;thead&gt;
 &lt;tr&gt;
 &lt;th&gt;Indicator&lt;/th&gt;
 &lt;th style="text-align: right"&gt;Level&lt;/th&gt;
 &lt;th style="text-align: right"&gt;Change&lt;/th&gt;
 &lt;/tr&gt;
 &lt;/thead&gt;
 &lt;tbody&gt;
 &lt;tr&gt;
 &lt;td&gt;KOSPI&lt;/td&gt;
 &lt;td style="text-align: right"&gt;5,290.5&lt;/td&gt;
 &lt;td style="text-align: right"&gt;+5.4% (5-day window)&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;KOSDAQ&lt;/td&gt;
 &lt;td style="text-align: right"&gt;699.7&lt;/td&gt;
 &lt;td style="text-align: right"&gt;+9.5% (5-day window)&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;USD/KRW&lt;/td&gt;
 &lt;td style="text-align: right"&gt;1,336&lt;/td&gt;
 &lt;td style="text-align: right"&gt;-2.0%&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;VIX&lt;/td&gt;
 &lt;td style="text-align: right"&gt;18.4&lt;/td&gt;
 &lt;td style="text-align: right"&gt;-7.8%&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;Brent&lt;/td&gt;
 &lt;td style="text-align: right"&gt;$95.7&lt;/td&gt;
 &lt;td style="text-align: right"&gt;+3.4%&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;US 10Y&lt;/td&gt;
 &lt;td style="text-align: right"&gt;5.10%&lt;/td&gt;
 &lt;td style="text-align: right"&gt;+0.24pp&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/tbody&gt;
&lt;/table&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;Regime verdict:&lt;/strong&gt; Korea is withheld. The raw signal reads Bear, but one input is stale (futures open interest, 3 sessions old), so the label was not committed. US is Neutral. The 10-year yield rise breached the model&amp;rsquo;s 0.15pp threshold.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Data note:&lt;/strong&gt; Index levels are Yahoo quotes that may be intraday. The daily-bar close was 5,315.45 for KOSPI and 708.22 for KOSDAQ. Changes are 5-day windows, not one-day moves.&lt;/li&gt;
&lt;/ul&gt;
&lt;h2 id="market-wrap"&gt;Market Wrap
&lt;/h2&gt;&lt;p&gt;The Korea stock market bounced hard this week, but participation is still narrow. KOSPI is up 5.4% and KOSDAQ 9.5% over five days. Only 21.0% of the 2,692 stocks screened trade above their 50-day average. For the 200-day average the share is 15.6%. Both KOSPI and KOSDAQ remain below their 200-day averages.&lt;/p&gt;
&lt;p&gt;Today was selective. Of 2,592 stocks, 1,196 rose, 1,130 fell and 266 were flat. The advance/decline ratio was 105.8, and the average stock gained 0.20%.&lt;/p&gt;
&lt;p&gt;Financials led. KB Financial (105560.KS) gained 4.74%. Hana Financial (086790.KS) rose 3.40%. BNK Financial (138930.KS) climbed 6.48%. Brokers also moved up. Samsung Securities (016360.KS) added 3.50% and NH Investment &amp;amp; Securities (005940.KS) 3.39%.&lt;/p&gt;
&lt;p&gt;Utilities and internet names lagged. KEPCO (015760.KS) dropped 9.79%. NAVER (035420.KS) fell 5.12%. Doosan (000150.KS) lost 8.55%.&lt;/p&gt;
&lt;p&gt;Flow data pointed in two directions. Foreign investors were top net buyers of Samsung SDI (006400.KS), KB Financial, Hyundai Motor (005380.KS) and Hana Financial. They were top net sellers of KEPCO, NAVER and Samsung Securities. Institutions bought brokers and financials, including Samsung Securities, Korea Investment Holdings (071050.KS) and NH Investment &amp;amp; Securities. They sold NAVER, KEPCO and Doosan. The source gives rankings only, with no amounts.&lt;/p&gt;
&lt;p&gt;The derivatives picture is mixed. Program trading showed net buying of about 339 billion won on Nov 12. Futures basis was -6.07, which means futures traded below spot. ETF net creation was about 1.55 trillion won on Nov 11. These figures are one to two sessions old.&lt;/p&gt;
&lt;h2 id="todays-quality-re-rating-candidates"&gt;Today&amp;rsquo;s Quality Re-Rating Candidates
&lt;/h2&gt;&lt;p&gt;The framework has three layers. &lt;strong&gt;Quality&lt;/strong&gt; asks whether the business earns good returns. &lt;strong&gt;Money flow&lt;/strong&gt; asks whether foreign and institutional buyers are absorbing retail selling. &lt;strong&gt;Re-rating&lt;/strong&gt; asks whether earnings or the cycle are improving enough for the market to reprice the stock.&lt;/p&gt;
&lt;p&gt;The KR Meta Screener ranks names by family score. Historically, the financial-factor families (Quality, Smart Money Quality, Cycle, Smart Money Earnings) added little in forward-return tests. Estimate-upgrade signals added the most. The meta order is therefore not the same as a simple overlap count. The Intersection Summary found no 2+ overlap among the PEAD source it included today, so the meta list is the primary queue.&lt;/p&gt;
&lt;table&gt;
 &lt;thead&gt;
 &lt;tr&gt;
 &lt;th style="text-align: right"&gt;Meta rank&lt;/th&gt;
 &lt;th&gt;Ticker&lt;/th&gt;
 &lt;th&gt;Name&lt;/th&gt;
 &lt;th style="text-align: right"&gt;Families&lt;/th&gt;
 &lt;th&gt;Key metrics&lt;/th&gt;
 &lt;/tr&gt;
 &lt;/thead&gt;
 &lt;tbody&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;1&lt;/td&gt;
 &lt;td&gt;086450.KQ&lt;/td&gt;
 &lt;td&gt;Dongkook Pharmaceutical&lt;/td&gt;
 &lt;td style="text-align: right"&gt;4&lt;/td&gt;
 &lt;td&gt;ROE 9.9%, OP +20.1% YoY, 5-day foreign + quality-institution net buying 4.6bn won&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;2&lt;/td&gt;
 &lt;td&gt;089890.KQ&lt;/td&gt;
 &lt;td&gt;Coses&lt;/td&gt;
 &lt;td style="text-align: right"&gt;2&lt;/td&gt;
 &lt;td&gt;Q3 OP +3,432% YoY, OPM 30.0%, 5-day return +41.6%&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;3&lt;/td&gt;
 &lt;td&gt;002900.KS&lt;/td&gt;
 &lt;td&gt;TYM&lt;/td&gt;
 &lt;td style="text-align: right"&gt;2&lt;/td&gt;
 &lt;td&gt;Estimate revision z +0.76, buyback decided Nov 11&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;4&lt;/td&gt;
 &lt;td&gt;068270.KS&lt;/td&gt;
 &lt;td&gt;Celltrion&lt;/td&gt;
 &lt;td style="text-align: right"&gt;3&lt;/td&gt;
 &lt;td&gt;Foreign + institution 5-day net buying 54.1bn won, retail selling 97.2bn won&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;5&lt;/td&gt;
 &lt;td&gt;064290.KQ&lt;/td&gt;
 &lt;td&gt;Intekplus&lt;/td&gt;
 &lt;td style="text-align: right"&gt;2&lt;/td&gt;
 &lt;td&gt;Estimate revision z +0.62, supply contract Nov 9, flow caution&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;6&lt;/td&gt;
 &lt;td&gt;002790.KS&lt;/td&gt;
 &lt;td&gt;Amorepacific Holdings&lt;/td&gt;
 &lt;td style="text-align: right"&gt;2&lt;/td&gt;
 &lt;td&gt;RS80 leadership, quiet foreign accumulation, treasury share disposal&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;7&lt;/td&gt;
 &lt;td&gt;026960.KS&lt;/td&gt;
 &lt;td&gt;Dongsuh&lt;/td&gt;
 &lt;td style="text-align: right"&gt;2&lt;/td&gt;
 &lt;td&gt;RS80 not-late, foreign holdings rising&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;8&lt;/td&gt;
 &lt;td&gt;089590.KS&lt;/td&gt;
 &lt;td&gt;Jeju Air&lt;/td&gt;
 &lt;td style="text-align: right"&gt;1&lt;/td&gt;
 &lt;td&gt;Estimate revision z +5.10, retail selling absorbed&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/tbody&gt;
&lt;/table&gt;
&lt;p&gt;&lt;strong&gt;Dongkook Pharmaceutical (086450.KQ)&lt;/strong&gt; is the only name hitting four families: Quality Compounder, Smart Money Quality, Cycle Rerating and PEAD. Foreign and quality-institution investors absorbed 5.3bn won of retail selling. The only recent filing is a routine shareholder-meeting notice. The financials behind the screen are FY2025 Q4 data, 246 days old. Next check: whether Q3 results confirm the margin gain, which is only +0.5pp.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Coses (089890.KQ)&lt;/strong&gt;, a semiconductor equipment maker, has the strongest earnings headline. Q3 revenue rose 76.9%, with margin up 29.2pp from a low base. The Nov 12 quarterly report is on file, and two supply-contract amendments are logged as catalysts. The stock is up 41.6% in five days, so chase risk is high. Next check: the contract sizes and whether the flow persists after the jump.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;TYM (002900.KS)&lt;/strong&gt;, a tractor maker, appears on upward estimate revisions and PEAD. A buyback decision (Nov 11) and a Q3 report (Nov 13) are the catalysts. The PEAD metrics come from a Q2 snapshot, so the Q3 filing needs a re-check.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Celltrion (068270.KS)&lt;/strong&gt; sits at meta rank 4 despite the highest family score (69.2). Its three families are Smart Money Quality, Cycle Rerating and RS80 leadership. It filed a treasury-share buyback result on Nov 13. The margin figure (+14.2pp) also uses FY2025 Q4 data and needs a refresh.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Caution:&lt;/strong&gt; Intekplus (064290.KQ) shows foreign and quality-institution net selling of 7.4bn won over five days, absorbed by retail buyers. That runs against the flow layer.&lt;/p&gt;
&lt;p&gt;These are screened candidates for follow-up research, not recommendations.&lt;/p&gt;</description></item><item><title>Korea Quality Re-Rating Watch 11-12: Dongkook, TYM, Celltrion</title><link>https://koreainvestinsights.com/post/kr-daily-wrap-2026-11-12/</link><pubDate>Thu, 12 Nov 2026 16:30:00 +0900</pubDate><guid>https://koreainvestinsights.com/post/kr-daily-wrap-2026-11-12/</guid><description>&lt;h2 id="macro-dashboard"&gt;Macro Dashboard
&lt;/h2&gt;&lt;table&gt;
 &lt;thead&gt;
 &lt;tr&gt;
 &lt;th&gt;Indicator&lt;/th&gt;
 &lt;th style="text-align: right"&gt;Level&lt;/th&gt;
 &lt;th style="text-align: right"&gt;Change&lt;/th&gt;
 &lt;/tr&gt;
 &lt;/thead&gt;
 &lt;tbody&gt;
 &lt;tr&gt;
 &lt;td&gt;KOSPI&lt;/td&gt;
 &lt;td style="text-align: right"&gt;5,342.73&lt;/td&gt;
 &lt;td style="text-align: right"&gt;+5.59% (5-day window)&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;KOSDAQ&lt;/td&gt;
 &lt;td style="text-align: right"&gt;696.53&lt;/td&gt;
 &lt;td style="text-align: right"&gt;+8.11% (5-day window)&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;USD/KRW&lt;/td&gt;
 &lt;td style="text-align: right"&gt;1,331.9&lt;/td&gt;
 &lt;td style="text-align: right"&gt;-1.80%&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;VIX&lt;/td&gt;
 &lt;td style="text-align: right"&gt;18.32&lt;/td&gt;
 &lt;td style="text-align: right"&gt;-28.55%&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;Brent&lt;/td&gt;
 &lt;td style="text-align: right"&gt;$92.05&lt;/td&gt;
 &lt;td style="text-align: right"&gt;-0.56%&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;US 10Y&lt;/td&gt;
 &lt;td style="text-align: right"&gt;5.00%&lt;/td&gt;
 &lt;td style="text-align: right"&gt;+0.16pp&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/tbody&gt;
&lt;/table&gt;
&lt;p&gt;&lt;strong&gt;Regime verdict:&lt;/strong&gt; Korea is withheld (UNKNOWN). The raw model signal is Bear, but one derivatives input (open interest) is two sessions old, so the label was not committed. The US is Neutral. It was downgraded from Bull because the 10-year yield rose more than 0.15pp.&lt;/p&gt;
&lt;p&gt;The index changes above are five-day windows built from Yahoo data. The source does not give a one-day change. The FinanceDataReader daily close was lower: 5,305.47 for KOSPI and 688.45 for KOSDAQ. Both indices sit well below their 200-day averages (KOSPI 6,520, KOSDAQ 961).&lt;/p&gt;
&lt;h2 id="market-wrap"&gt;Market Wrap
&lt;/h2&gt;&lt;p&gt;The KOSPI and Korea stock market bounce is real at the index level. The average stock told a different story today.&lt;/p&gt;
&lt;p&gt;Of 2,595 stocks, 743 rose, 1,591 fell and 261 were flat. The advance/decline proxy was 46.7 and the average stock fell 0.76%. Only 20.1% of the 2,692 stocks in the screening universe trade above their 50-day average. That figure is 15.2% against the 200-day average. This was a selective, narrow session, not a broad rally.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Weak spots:&lt;/strong&gt; Several mid-caps fell sharply and appeared on the foreign selling list. DB HiTek (000990.KS) fell 16.36%, Dalba Global (483650.KS) fell 13.97%, and SPG (058610.KS) fell 16.09%. On the institutional selling list, NC (036570.KS) fell 9.19%, NAVER (035420.KS) fell 6.43% and Meritz Financial Holdings (138040.KS) fell 13.05%. Hyundai Motor (005380.KS) fell 2.20%.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Flow signals:&lt;/strong&gt; Foreigners ranked financials high among net buyers: KB Financial (105560.KS), Shinhan Financial (055550.KS) and Hana Financial (086790.KS), even though KB and Shinhan slipped. Institutions were net sellers of the same three names. Institutions bought smaller, higher-volatility names such as Estec (069510.KS, +19.83%), HYBE (352820.KS, +5.35%) and Samyang Foods (003230.KS, +4.46%). The source gives rankings only. Net buying amounts and turnover were not available.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Derivatives and passive flow:&lt;/strong&gt; Program trading was a net buy of about 338.9 billion won. Basis was -6.07, and net ETF creation was about 1.55 trillion won. Open interest was 83,678, but that reading dates from Nov 10.&lt;/p&gt;
&lt;p&gt;The macro backdrop is mixed. The won strengthened and VIX fell. The US 10-year yield rose to 5.00%, and the dollar index rose to 102.9.&lt;/p&gt;
&lt;h2 id="todays-quality-re-rating-candidates"&gt;Today&amp;rsquo;s Quality Re-Rating Candidates
&lt;/h2&gt;&lt;p&gt;The screen asks for three layers. The first is &lt;strong&gt;quality&lt;/strong&gt;: a business with solid returns and growing profit. The second is &lt;strong&gt;money flow&lt;/strong&gt;: foreign and quality-institution buying that absorbs individual selling. The third is a &lt;strong&gt;re-rating or earnings catalyst&lt;/strong&gt;: margin expansion, estimate upgrades, or post-earnings drift (PEAD).&lt;/p&gt;
&lt;p&gt;The strict overlap check found no stock in two or more of the screeners it reads. That check read only the PEAD screener today. The KR Meta Screener, which combines several screener families, supplies the ranking below. Its weights favor consensus-upgrade signals (weight 2.18) over the four financial-factor screens (0.54), which have lagged their candidate pool recently.&lt;/p&gt;
&lt;table&gt;
 &lt;thead&gt;
 &lt;tr&gt;
 &lt;th style="text-align: right"&gt;Rank&lt;/th&gt;
 &lt;th&gt;Ticker&lt;/th&gt;
 &lt;th&gt;Name&lt;/th&gt;
 &lt;th style="text-align: right"&gt;Families&lt;/th&gt;
 &lt;th&gt;Key metrics&lt;/th&gt;
 &lt;/tr&gt;
 &lt;/thead&gt;
 &lt;tbody&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;1&lt;/td&gt;
 &lt;td&gt;086450.KS&lt;/td&gt;
 &lt;td&gt;Dongkook Pharmaceutical&lt;/td&gt;
 &lt;td style="text-align: right"&gt;4&lt;/td&gt;
 &lt;td&gt;ROE 9.9%, OP +20.1% YoY, margin +0.5pp, RS 90&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;2&lt;/td&gt;
 &lt;td&gt;002900.KS&lt;/td&gt;
 &lt;td&gt;TYM&lt;/td&gt;
 &lt;td style="text-align: right"&gt;2&lt;/td&gt;
 &lt;td&gt;Consensus z +0.74, OP +298% YoY, buyback decision Nov 11&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;3&lt;/td&gt;
 &lt;td&gt;068270.KS&lt;/td&gt;
 &lt;td&gt;Celltrion&lt;/td&gt;
 &lt;td style="text-align: right"&gt;3&lt;/td&gt;
 &lt;td&gt;OP +137.5% YoY, margin +14.2pp, 4 catalyst filings&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;4&lt;/td&gt;
 &lt;td&gt;121600.KQ&lt;/td&gt;
 &lt;td&gt;Nano Advanced Materials&lt;/td&gt;
 &lt;td style="text-align: right"&gt;2&lt;/td&gt;
 &lt;td&gt;5-day foreign + quality-institution buying +17.2bn won, margin +0.8pp&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;5&lt;/td&gt;
 &lt;td&gt;002790.KS&lt;/td&gt;
 &lt;td&gt;Amorepacific Holdings&lt;/td&gt;
 &lt;td style="text-align: right"&gt;2&lt;/td&gt;
 &lt;td&gt;Quiet accumulation, pivot gap +5.0%, RS80 pass&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;6&lt;/td&gt;
 &lt;td&gt;089590.KS&lt;/td&gt;
 &lt;td&gt;Jeju Air&lt;/td&gt;
 &lt;td style="text-align: right"&gt;1&lt;/td&gt;
 &lt;td&gt;Consensus z +5.10, individual selling absorbed (14.2bn won)&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;7&lt;/td&gt;
 &lt;td&gt;272450.KS&lt;/td&gt;
 &lt;td&gt;Jin Air&lt;/td&gt;
 &lt;td style="text-align: right"&gt;1&lt;/td&gt;
 &lt;td&gt;Consensus z +0.67, two IR filings&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;8&lt;/td&gt;
 &lt;td&gt;020150.KS&lt;/td&gt;
 &lt;td&gt;Lotte Energy Materials&lt;/td&gt;
 &lt;td style="text-align: right"&gt;1&lt;/td&gt;
 &lt;td&gt;Consensus z +1.42, 5 catalyst filings&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/tbody&gt;
&lt;/table&gt;
&lt;p&gt;&lt;strong&gt;Dongkook Pharmaceutical (086450.KS)&lt;/strong&gt; is a Korean drugmaker. It leads because four screener families flag it: Quality Compounder, Cycle Rerating, PEAD and Quiet Accumulation. Foreign and quality-institution buyers absorbed about 4.9 billion won of individual selling. The only recent DART filing is a shareholder meeting notice, so no company-specific catalyst is visible. The financials come from the 2025 annual filing, which is 245 days old. The next check is the latest quarterly report, to confirm the margin trend still holds.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;TYM (002900.KS)&lt;/strong&gt; makes agricultural machinery. Its case rests on estimate upgrades and official events. The company filed a treasury share buyback decision on Nov 11 and preliminary earnings on Nov 4. The PEAD screen shows operating profit up about 298% year on year, but that figure comes from a snapshot source with no filing date. It is a growth filter, not a consensus surprise. Check the earnings release and the buyback size.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Celltrion (068270.KS)&lt;/strong&gt; is a biosimilar maker. It is flagged for margin expansion (+14.2pp), PEAD and RS80 leadership, and about 100 billion won of individual selling was absorbed by foreign and quality-institution buyers. DART shows a catalyst filing on Nov 2: a European Phase 3 trial plan for its CTP13 subcutaneous product in rheumatoid arthritis. The financial data is also from the 2025 annual filing. The next check is the Q3 numbers and the trial timeline.&lt;/p&gt;
&lt;p&gt;Nano Advanced Materials (121600.KQ) has the strongest money-flow evidence outside the top three. It also filed a share cancellation decision today. Korean Air (003490.KS) and Samah Aluminum (006110.KS) appear in the full ranking, with consensus upgrades as their only screen signal.&lt;/p&gt;
&lt;p&gt;All names are screened candidates for further research, not recommendations. KT Genie Music (043610.KS) carries one DART risk-type filing and is excluded from the top table.&lt;/p&gt;
&lt;p&gt;&lt;em&gt;Sources: KR Meta Screener, KR PEAD screener, macro regime model and Research OS snapshot, all dated 2026-11-12. Yahoo index levels are intraday-capable regular market prices.&lt;/em&gt;&lt;/p&gt;</description></item><item><title>Korea Quality Re-Rating Watch Nov 11: Dongkook Pharm, Nanosys, TYM</title><link>https://koreainvestinsights.com/post/kr-daily-wrap-2026-11-11/</link><pubDate>Wed, 11 Nov 2026 16:30:00 +0900</pubDate><guid>https://koreainvestinsights.com/post/kr-daily-wrap-2026-11-11/</guid><description>&lt;h2 id="macro-dashboard"&gt;Macro Dashboard
&lt;/h2&gt;&lt;table&gt;
 &lt;thead&gt;
 &lt;tr&gt;
 &lt;th&gt;Indicator&lt;/th&gt;
 &lt;th&gt;Value&lt;/th&gt;
 &lt;th&gt;Change / Note&lt;/th&gt;
 &lt;/tr&gt;
 &lt;/thead&gt;
 &lt;tbody&gt;
 &lt;tr&gt;
 &lt;td&gt;KOSPI&lt;/td&gt;
 &lt;td&gt;—&lt;/td&gt;
 &lt;td&gt;Index level unavailable in today&amp;rsquo;s snapshot&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;KOSDAQ&lt;/td&gt;
 &lt;td&gt;—&lt;/td&gt;
 &lt;td&gt;Index level unavailable&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;USD/KRW&lt;/td&gt;
 &lt;td&gt;1,361.89&lt;/td&gt;
 &lt;td&gt;Stale (as of Nov 6); +22.86 over 5 sessions&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;KR 10Y&lt;/td&gt;
 &lt;td&gt;3.85%&lt;/td&gt;
 &lt;td&gt;As of Nov 10; −0.15pp over 5 sessions&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;US 10Y&lt;/td&gt;
 &lt;td&gt;4.88%&lt;/td&gt;
 &lt;td&gt;As of Nov 9; −0.03pp over 5 sessions&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;HY OAS&lt;/td&gt;
 &lt;td&gt;3.34%&lt;/td&gt;
 &lt;td&gt;−0.09pp; credit remains benign&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;DXY&lt;/td&gt;
 &lt;td&gt;102.24&lt;/td&gt;
 &lt;td&gt;+0.37 over 5 sessions&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;KR / US Regime&lt;/td&gt;
 &lt;td&gt;&lt;strong&gt;BLOCKED&lt;/strong&gt;&lt;/td&gt;
 &lt;td&gt;Regime verdict withheld — ETF creation proxy stale&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/tbody&gt;
&lt;/table&gt;
&lt;p&gt;The macro pipeline withheld its KR/US regime verdict today due to a stale derivative input (&lt;code&gt;kr_derivative:etf_creation_proxy:2d&lt;/code&gt;). Partial evidence (13/15 period checks clear) is available but insufficient for a formal bull/neutral/bear call. The directional skew is constructive — Korean yields falling, US HY spreads narrow — but no regime label is issued until the blocked input is refreshed.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id="market-wrap"&gt;Market Wrap
&lt;/h2&gt;&lt;p&gt;November 11 was a broad, high-conviction advance. Of 2,593 tracked stocks, &lt;strong&gt;1,670 gained, 680 fell, 243 were unchanged&lt;/strong&gt; — a 71% advance rate. The ADR proxy printed 245.6 and the average stock returned +1.81%. This is not an index-driven headline move; participation was genuine and wide.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Themes that led:&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Secondary battery&lt;/strong&gt; dominated. Eco-Pro (086520.KQ) surged +10.03% with foreign net buying. Eco-Pro BM (247540.KQ) added +11.39% on institutional accumulation. Samsung SDI (006400.KS, +4.93%) attracted both foreign and institutional buyers simultaneously — the cleanest two-sided confirmation in the space today.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Semiconductor back-end and PCB&lt;/strong&gt; saw explosive moves with institutional support. Korea Circuit (007810.KS) jumped +25.58% on institutional buying. TSI (131290.KQ, +23.24%) also attracted institutional flows, but foreign investors were net sellers — a split-flow reading that warrants caution before extrapolating.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Pharma and bio&lt;/strong&gt; featured strong institutional demand. Hanmi Pharmaceutical (128940.KS, +5.27%), Ligachem Biosciences (141080.KQ, +10.79%), and ABL Bio (298380.KQ, +13.48%) all recorded institutional net buying.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Weak pockets:&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Insurance was the most notable sector under pressure. Samsung Fire (000810.KS, −5.51%), Hyundai Marine (001450.KS, −3.00%), and DB Insurance (005830.KS, −1.63%) declined with institutional selling. Lunit (328130.KQ, −16.03%) was the session&amp;rsquo;s sharpest institutional net sell. Emart (139480.KS, −8.05%) and Korea Zinc (010130.KS, −4.96%) also underperformed.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Flow character:&lt;/strong&gt; The dominant pattern today was retail supply absorbed by foreign and institutional buyers across multiple names and sectors — constructive distribution dynamics in a broad risk-on session.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id="todays-quality-re-rating-candidates"&gt;Today&amp;rsquo;s Quality Re-Rating Candidates
&lt;/h2&gt;&lt;p&gt;Today&amp;rsquo;s meta screener covered 107 names across 8 screener families. No name cleared the 2+ raw overlap threshold in the intersection check, but the Meta Screener&amp;rsquo;s weighted scoring — which penalizes single-source clustering and applies backtested family weights — surfaces a clear top tier. The consensus-revision family carries the highest empirically-derived weight (2.21×); financial-factor screens carry the lowest (0.55×). Rankings reflect these weights.&lt;/p&gt;
&lt;table&gt;
 &lt;thead&gt;
 &lt;tr&gt;
 &lt;th style="text-align: right"&gt;Rank&lt;/th&gt;
 &lt;th&gt;Ticker&lt;/th&gt;
 &lt;th&gt;Name&lt;/th&gt;
 &lt;th style="text-align: right"&gt;Screener Families&lt;/th&gt;
 &lt;th style="text-align: right"&gt;Family Score&lt;/th&gt;
 &lt;th&gt;Evidence Signals&lt;/th&gt;
 &lt;/tr&gt;
 &lt;/thead&gt;
 &lt;tbody&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;1&lt;/td&gt;
 &lt;td&gt;086450.KS&lt;/td&gt;
 &lt;td&gt;Dongkook Pharma&lt;/td&gt;
 &lt;td style="text-align: right"&gt;4&lt;/td&gt;
 &lt;td style="text-align: right"&gt;66.9&lt;/td&gt;
 &lt;td&gt;Quality + Cycle Rerating + PEAD + RS80&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;2&lt;/td&gt;
 &lt;td&gt;121600.KQ&lt;/td&gt;
 &lt;td&gt;Nanosys&lt;/td&gt;
 &lt;td style="text-align: right"&gt;4&lt;/td&gt;
 &lt;td style="text-align: right"&gt;55.0&lt;/td&gt;
 &lt;td&gt;Consensus Up + Cycle + Smart Money Earnings + Smart Money Quality&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;3&lt;/td&gt;
 &lt;td&gt;002790.KS&lt;/td&gt;
 &lt;td&gt;AmorePacific Holdings&lt;/td&gt;
 &lt;td style="text-align: right"&gt;3&lt;/td&gt;
 &lt;td style="text-align: right"&gt;30.7&lt;/td&gt;
 &lt;td&gt;Quiet Accumulation + RS80 + DART catalyst&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;4&lt;/td&gt;
 &lt;td&gt;002900.KS&lt;/td&gt;
 &lt;td&gt;TYM&lt;/td&gt;
 &lt;td style="text-align: right"&gt;2&lt;/td&gt;
 &lt;td style="text-align: right"&gt;27.6&lt;/td&gt;
 &lt;td&gt;Consensus Up + PEAD + DART catalyst&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;5&lt;/td&gt;
 &lt;td&gt;003490.KS&lt;/td&gt;
 &lt;td&gt;Korean Air&lt;/td&gt;
 &lt;td style="text-align: right"&gt;1&lt;/td&gt;
 &lt;td style="text-align: right"&gt;23.8&lt;/td&gt;
 &lt;td&gt;Consensus Up + Kiwoom surface&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;6&lt;/td&gt;
 &lt;td&gt;089590.KS&lt;/td&gt;
 &lt;td&gt;Jeju Air&lt;/td&gt;
 &lt;td style="text-align: right"&gt;1&lt;/td&gt;
 &lt;td style="text-align: right"&gt;23.3&lt;/td&gt;
 &lt;td&gt;Consensus Up&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;7&lt;/td&gt;
 &lt;td&gt;272450.KS&lt;/td&gt;
 &lt;td&gt;Jin Air&lt;/td&gt;
 &lt;td style="text-align: right"&gt;1&lt;/td&gt;
 &lt;td style="text-align: right"&gt;23.1&lt;/td&gt;
 &lt;td&gt;Consensus Up&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;8&lt;/td&gt;
 &lt;td&gt;128940.KS&lt;/td&gt;
 &lt;td&gt;Hanmi Pharmaceutical&lt;/td&gt;
 &lt;td style="text-align: right"&gt;1&lt;/td&gt;
 &lt;td style="text-align: right"&gt;22.4&lt;/td&gt;
 &lt;td&gt;Consensus Up + Kiwoom surface ⚠️ short 6.5%&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;9&lt;/td&gt;
 &lt;td&gt;144960.KQ&lt;/td&gt;
 &lt;td&gt;NuPower Plasma&lt;/td&gt;
 &lt;td style="text-align: right"&gt;2&lt;/td&gt;
 &lt;td style="text-align: right"&gt;21.9&lt;/td&gt;
 &lt;td&gt;Consensus Up + Smart Money Earnings&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;10&lt;/td&gt;
 &lt;td&gt;293490.KQ&lt;/td&gt;
 &lt;td&gt;Kakao Games&lt;/td&gt;
 &lt;td style="text-align: right"&gt;1&lt;/td&gt;
 &lt;td style="text-align: right"&gt;19.8&lt;/td&gt;
 &lt;td&gt;Consensus Up&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/tbody&gt;
&lt;/table&gt;
&lt;p&gt;&lt;strong&gt;Dongkook Pharma (086450.KS) — Rank 1 / Score 66.9&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;A mid-cap Korean pharmaceutical company focused on dermatology, wound care, and consumer OTC products. It clears four independent screener families today: Quality Compounder (ROE 9.9%, operating profit up +20.1% YoY), Cycle Rerating (margin expanding +0.5pp), PEAD (OP YoY growth screen), and RS80 Not-Late Leadership. The flow signal is clean — retail sold ₩5.83bn while foreign and quality-institutional buyers absorbed the supply. No DART filings appear in the 21-day lookback, so there is no discrete official catalyst; this is an operating-leverage-meets-money-flow story. &lt;strong&gt;Next check:&lt;/strong&gt; confirm whether margin expansion reflects durable product mix shift or one-time cost savings, and monitor DART for upcoming IR activity.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Nanosys (121600.KQ) — Rank 2 / Score 55.0&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;A specialty materials company operating in quantum dot and semiconductor materials. Clears four families: Consensus Up, Cycle Rerating (+0.8pp margin), Smart Money Earnings, and Smart Money Quality. The flow signal is the most explicit in today&amp;rsquo;s cohort: retail sold ₩16.89bn while foreign and quality-institutional absorbed — the largest retail net-sell differential among flagged names. Two DART catalysts are in the rearview: a self-share disposal (Nov 6) and an earnings disclosure (Nov 3). This is now a post-earnings drift candidate with live accumulation underway. &lt;strong&gt;Next check:&lt;/strong&gt; verify consensus estimate revisions using a broker source; underlying financials come from SNAP fallback and need DART-side confirmation before treating the numbers as final.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;TYM (002900.KS) — Rank 4 / Score 27.6&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;An agricultural machinery manufacturer. Scores on two families — Consensus Up and PEAD — with a live DART catalyst filed today: a self-share buyback decision (Nov 11). PEAD metrics are notably strong: OP YoY +298%, Δmargin +4.85pp, RS 86%, and 18.6% headroom to the 52-week high. The buyback adds shareholder-return credibility to what is otherwise an operating leverage story. &lt;strong&gt;Next check:&lt;/strong&gt; assess buyback size relative to free float; confirm whether revenue growth (+17.8% YoY) is structural or partly commodity-price-driven in the agricultural cycle.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Airline cluster note:&lt;/strong&gt; Korean Air (003490.KS), Jeju Air (089590.KS), and Jin Air (272450.KS) all show consensus upgrades with retail selling absorbed by institutional and foreign buyers, plus recent IR activity. Each scores as a single-family name, but the coordinated revision across the carrier group points to a thematic setup worth monitoring heading into peak travel season.&lt;/p&gt;
&lt;hr&gt;
&lt;p&gt;&lt;em&gt;Source: Research OS local DB as of 2026-11-11. Screener signals are research candidates, not investment recommendations. Macro regime verdict is withheld pending input refresh.&lt;/em&gt;&lt;/p&gt;</description></item><item><title>Korea Quality Re-Rating Watch 2026-11-10: Dongkuk Pharma, Nano New Material — Bear Bounce Surfaces Re-Pricers</title><link>https://koreainvestinsights.com/post/kr-daily-wrap-2026-11-10/</link><pubDate>Tue, 10 Nov 2026 16:30:00 +0900</pubDate><guid>https://koreainvestinsights.com/post/kr-daily-wrap-2026-11-10/</guid><description>&lt;h2 id="macro-dashboard"&gt;Macro Dashboard
&lt;/h2&gt;&lt;table&gt;
 &lt;thead&gt;
 &lt;tr&gt;
 &lt;th&gt;Indicator&lt;/th&gt;
 &lt;th&gt;Level&lt;/th&gt;
 &lt;th&gt;5-Day Change&lt;/th&gt;
 &lt;th&gt;Signal&lt;/th&gt;
 &lt;/tr&gt;
 &lt;/thead&gt;
 &lt;tbody&gt;
 &lt;tr&gt;
 &lt;td&gt;KOSPI&lt;/td&gt;
 &lt;td&gt;5,239&lt;/td&gt;
 &lt;td&gt;−7.8%&lt;/td&gt;
 &lt;td&gt;Bear&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;KOSDAQ&lt;/td&gt;
 &lt;td&gt;668&lt;/td&gt;
 &lt;td&gt;−6.6%&lt;/td&gt;
 &lt;td&gt;Bear&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;USD/KRW&lt;/td&gt;
 &lt;td&gt;1,339&lt;/td&gt;
 &lt;td&gt;−0.3%&lt;/td&gt;
 &lt;td&gt;Flat&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;VIX&lt;/td&gt;
 &lt;td&gt;20.2&lt;/td&gt;
 &lt;td&gt;+21.4%&lt;/td&gt;
 &lt;td&gt;Caution&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;US 10Y&lt;/td&gt;
 &lt;td&gt;4.86%&lt;/td&gt;
 &lt;td&gt;−9 bps&lt;/td&gt;
 &lt;td&gt;Flat&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;Brent&lt;/td&gt;
 &lt;td&gt;$91.1&lt;/td&gt;
 &lt;td&gt;−7.3%&lt;/td&gt;
 &lt;td&gt;Weak&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;DXY&lt;/td&gt;
 &lt;td&gt;101.7&lt;/td&gt;
 &lt;td&gt;Flat&lt;/td&gt;
 &lt;td&gt;—&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/tbody&gt;
&lt;/table&gt;
&lt;p&gt;&lt;strong&gt;KR regime: Bear | US regime: Neutral&lt;/strong&gt; (as of 2026-11-10 20:20 KST; 11/12 inputs current)&lt;/p&gt;
&lt;p&gt;Both KOSPI and KOSDAQ remain well below their 200-day moving averages. Only 17.7% of 2,692 tracked Korean stocks trade above their 50-day average — bear breadth by any measure. The US regime slipped from Bull to Neutral after VIX crossed 20 (20.17 current), capping the index-based Bull read. Korean breadth at 17.7% vs. US at 39.0% marks a substantial divergence. Brent&amp;rsquo;s -7.3% five-day slide and a negative futures basis (−2.21) add macro headwinds for Korea&amp;rsquo;s energy-linked names.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id="market-wrap"&gt;Market Wrap
&lt;/h2&gt;&lt;p&gt;&lt;em&gt;Source: KR Market Snapshot (2026-11-10 DB). Full close briefing not available; trading summary derived from same-day DB.&lt;/em&gt;&lt;/p&gt;
&lt;p&gt;Today&amp;rsquo;s session delivered a sharp breadth reversal inside a confirmed bear regime. Of 2,593 tracked names, 1,906 advanced against 462 decliners (ADR proxy 412.6), with the average stock gaining +2.57%. The regime data reflects cumulative five-day damage — KOSPI −7.8%, KOSDAQ −6.6% — but today itself was Day 1 of a rally attempt. The character: broad, sector-led, with meaningful double-sided institutional commitment in select names.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Airlines and travel&lt;/strong&gt; led the session decisively. Korean Air (003490.KS, +11.51%) attracted both foreign and institutional net buying, a rare simultaneous inflow that signals conviction rather than a short-covering flush. Hanjin KAL (180640.KS) surged +15.18% and Daewoo E&amp;amp;C (047040.KS) added +9.21% with foreign support. The move reads as capacity-recovery positioning; Jeju Air (089590.KQ) and Jin Air (272450.KQ) are screened candidates in the same theme (see Section 3).&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Battery and secondary-cell&lt;/strong&gt; names saw coordinated buying. Samsung SDI (006400.KS, +9.88%) drew foreign &lt;em&gt;and&lt;/em&gt; institutional inflows simultaneously — the kind of double conviction that tends to mark a durable floor attempt. Eco Pro (086520.KS, +10.23%) and Eco Pro BM (247540.KS, +8.70%) were institutional-led. LG Energy Solution (373220.KS, +3.93%) attracted institutional buying despite foreign selling, suggesting domestic funds used the dip to reload. The common thread: battery raw material and cell names moving together on institutional direction.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Industrials and special situations&lt;/strong&gt; added breadth. HD Construction Machinery (267270.KS, +12.30%) was institutional-bought. SFA Semiconductor (036540.KS, +13.17%) and Exicon (092870.KS, +13.14%) surged but on foreign selling — a retail/institutional divergence worth watching.&lt;/p&gt;
&lt;p&gt;Weak spots were concentrated: KT&amp;amp;G (033780.KS, −3.67%) saw both foreign and institutional selling, standing out as the clearest risk-off name on a broadly green tape. Samsung Biologics (207940.KS, −2.78%) and KT (030200.KS, −2.30%) also faced institutional outflows. The pattern — quality defensives and telecom underperforming on a bounce day — suggests the rotation was pro-cyclical and sentiment-driven rather than a defensive rotation.&lt;/p&gt;
&lt;p&gt;The bear regime label reflects cumulative breadth damage; today&amp;rsquo;s session does not invalidate it. The next confirmation of a rally attempt requires a follow-through day on higher volume in the coming sessions.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id="todays-quality-re-rating-candidates"&gt;Today&amp;rsquo;s Quality Re-Rating Candidates
&lt;/h2&gt;&lt;p&gt;Today&amp;rsquo;s meta screener processed 103 tickers, scoring by weighted multi-family signal overlap. The empirical weights place earnings estimate revision (2.22×) and RS80 price leadership (1.34×) above the financial-factor cluster (0.56×). No pure two-screener PEAD intersection emerged in isolation, but the meta screener&amp;rsquo;s multi-family detection surfaces one clear leader and several credible second-tier candidates.&lt;/p&gt;
&lt;table&gt;
 &lt;thead&gt;
 &lt;tr&gt;
 &lt;th&gt;Rank&lt;/th&gt;
 &lt;th&gt;Ticker&lt;/th&gt;
 &lt;th&gt;Name&lt;/th&gt;
 &lt;th&gt;Families&lt;/th&gt;
 &lt;th&gt;Score&lt;/th&gt;
 &lt;th&gt;Screeners Hit&lt;/th&gt;
 &lt;th&gt;Key Metrics&lt;/th&gt;
 &lt;/tr&gt;
 &lt;/thead&gt;
 &lt;tbody&gt;
 &lt;tr&gt;
 &lt;td&gt;1&lt;/td&gt;
 &lt;td&gt;086450.KS&lt;/td&gt;
 &lt;td&gt;Dongkuk Pharmaceutical&lt;/td&gt;
 &lt;td&gt;4&lt;/td&gt;
 &lt;td&gt;81.3&lt;/td&gt;
 &lt;td&gt;Quality Compounder, Cycle Rerating, PEAD, Quiet Accumulation&lt;/td&gt;
 &lt;td&gt;ROE 9.9%, OP YoY +20%, Δmargin +0.5pp&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;2&lt;/td&gt;
 &lt;td&gt;121600.KQ&lt;/td&gt;
 &lt;td&gt;Nano New Material&lt;/td&gt;
 &lt;td&gt;2&lt;/td&gt;
 &lt;td&gt;32.3&lt;/td&gt;
 &lt;td&gt;Cycle Rerating, Consensus Up&lt;/td&gt;
 &lt;td&gt;Δmargin +0.8pp, consensus z +0.65&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;3&lt;/td&gt;
 &lt;td&gt;002790.KS&lt;/td&gt;
 &lt;td&gt;Amorepacific Holdings&lt;/td&gt;
 &lt;td&gt;2&lt;/td&gt;
 &lt;td&gt;30.4&lt;/td&gt;
 &lt;td&gt;Quiet Accumulation, RS80&lt;/td&gt;
 &lt;td&gt;Pivot gap +4.3%, box risk −17.0%&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;4&lt;/td&gt;
 &lt;td&gt;002900.KS&lt;/td&gt;
 &lt;td&gt;TYM&lt;/td&gt;
 &lt;td&gt;2&lt;/td&gt;
 &lt;td&gt;24.4&lt;/td&gt;
 &lt;td&gt;Consensus Up, PEAD&lt;/td&gt;
 &lt;td&gt;OP YoY +298%, consensus z +0.72&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;5&lt;/td&gt;
 &lt;td&gt;089590.KQ&lt;/td&gt;
 &lt;td&gt;Jeju Air&lt;/td&gt;
 &lt;td&gt;1&lt;/td&gt;
 &lt;td&gt;23.3&lt;/td&gt;
 &lt;td&gt;Consensus Up&lt;/td&gt;
 &lt;td&gt;Consensus z +5.57, IR event filed&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;6&lt;/td&gt;
 &lt;td&gt;003670.KS&lt;/td&gt;
 &lt;td&gt;POSCO Future M&lt;/td&gt;
 &lt;td&gt;1&lt;/td&gt;
 &lt;td&gt;22.6&lt;/td&gt;
 &lt;td&gt;Consensus Up&lt;/td&gt;
 &lt;td&gt;Consensus z +0.95, preliminary earnings filed&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;7&lt;/td&gt;
 &lt;td&gt;272450.KQ&lt;/td&gt;
 &lt;td&gt;Jin Air&lt;/td&gt;
 &lt;td&gt;1&lt;/td&gt;
 &lt;td&gt;21.9&lt;/td&gt;
 &lt;td&gt;Consensus Up&lt;/td&gt;
 &lt;td&gt;Consensus z +0.63, two IR events filed&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;8&lt;/td&gt;
 &lt;td&gt;293490.KQ&lt;/td&gt;
 &lt;td&gt;Kakao Games&lt;/td&gt;
 &lt;td&gt;1&lt;/td&gt;
 &lt;td&gt;20.0&lt;/td&gt;
 &lt;td&gt;Consensus Up&lt;/td&gt;
 &lt;td&gt;Consensus z +0.55, earnings + IR catalyst&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/tbody&gt;
&lt;/table&gt;
&lt;h3 id="dongkuk-pharmaceutical-086450ks--four-family-leader"&gt;Dongkuk Pharmaceutical (086450.KS) — four-family leader
&lt;/h3&gt;&lt;p&gt;Dongkuk Pharma is a mid-cap Korean specialty pharmaceutical and consumer health company. It is the only name today passing four independent screener families: Quality Compounder, Cycle Rerating, PEAD, and Quiet Accumulation — producing a composite score of 81.3, nearly 2.5× its nearest rival. ROE stands at 9.9%, operating profit grew +20% YoY with margin expansion of +0.5pp, and the stock sits +10.2% below its 52-week high with a positive MA50 confirmation. Retail outflows of −5.75bn won are being absorbed by foreign and quality-institutional buyers. The DART filing lookback shows no risk filings in the 21-day window. The key check: determine whether the YoY operating leverage reflects a structural cost shift or a base-effect quarter. The post-earnings drift window remains open.&lt;/p&gt;
&lt;h3 id="nano-new-material-121600kq--cycle-plus-consensus"&gt;Nano New Material (121600.KQ) — cycle plus consensus
&lt;/h3&gt;&lt;p&gt;This KOSDAQ-listed advanced materials company — a supplier of CMP slurry and functional film to semiconductor fabs — hits both Cycle Rerating and Consensus Up. Operating margin expanded +0.8pp; consensus composite z-score is +0.65. Foreign and institutional buyers are absorbing −10.39bn won in retail supply. A Nov 6 DART filing for treasury share disposal adds a corporate action catalyst. The re-rating logic is straightforward: semiconductor fab utilization recovery feeds consumables demand, and analysts are beginning to price it in. Liquidity is thin; position sizing requires a volume check before entry.&lt;/p&gt;
&lt;h3 id="amorepacific-holdings-002790ks--quiet-accumulation-plus-price-leadership"&gt;Amorepacific Holdings (002790.KS) — quiet accumulation plus price leadership
&lt;/h3&gt;&lt;p&gt;Korea&amp;rsquo;s largest cosmetics holding company passes Quiet Accumulation (foreign ownership rising in a narrow price range) and RS80 Not-Late Leadership (Focus Candidate tier, pivot gap +4.3%, box risk −17.0%). A self-tender buyback completion filed with DART on Nov 2 is the official corporate catalyst. The re-rating question hinges on China consumer recovery: does the next quarterly earnings print show volume inflection in the Greater China segment? Consensus was revised upward four times in the DART lookback window. Worth monitoring for the earnings follow-through.&lt;/p&gt;
&lt;hr&gt;
&lt;p&gt;&lt;em&gt;Screener data: KR Meta Screener 2026-11-10. Market snapshot: same-day DB. Macro regime: 11/12 inputs current as of 20:20 KST. Candidates flagged for further research; not investment recommendations.&lt;/em&gt;&lt;/p&gt;</description></item></channel></rss>